These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24713413)

  • 1. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
    Petraglia F; Parke S; Serrani M; Mellinger U; Römer T
    Int J Gynaecol Obstet; 2014 Jun; 125(3):270-4. PubMed ID: 24713413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W; Mellinger U; Parke S; Serrani M
    Clin Drug Investig; 2011; 31(8):573-584. PubMed ID: 21721593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
    J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dienogest-containing oral contraceptives on lipid metabolism.
    Wiegratz I; Lee JH; Kutschera E; Bauer HH; von Hayn C; Moore C; Mellinger U; Winkler UH; Gross W; Kuhl H
    Contraception; 2002 Mar; 65(3):223-9. PubMed ID: 11929644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
    Fraser IS; Römer T; Parke S; Zeun S; Mellinger U; Machlitt A; Jensen JT
    Hum Reprod; 2011 Oct; 26(10):2698-708. PubMed ID: 21784734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
    Uysal G; Akkaya H; Cagli F; Tutus S; Tayyar AT
    J Obstet Gynaecol; 2018 Aug; 38(6):828-832. PubMed ID: 29537325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
    Wiegratz I; Kutschera E; Lee JH; Moore C; Mellinger U; Winkler UH; Kuhl H
    Contraception; 2003 Jan; 67(1):25-32. PubMed ID: 12521654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
    Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM; Martell CW
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C; Duijkers I; Parke S; Mellinger U; Serrani M; Junge W
    Drugs R D; 2011; 11(2):159-70. PubMed ID: 21679006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
    Wiegratz I; Kutschera E; Lee JH; Moore C; Mellinger U; Winkler UH; Kuhl H
    Contraception; 2003 May; 67(5):361-6. PubMed ID: 12742558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
    Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
    Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.